Fluorescent In Situ Hybridization Probe Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Technology (Q FISH, FLOW FISH, Others), By Type (DNA, RNA (mRNA, miRNA, Others)), By Application (Cancer Research, Genetic Diseases, Others), By End-Use (Research, Clinical, Companion Diagnostics), By Region, & Competition, 2020-2030F
Global Fluorescent In Situ Hybridization Probe Market was valued at USD 981.50 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2030. The Global Fluorescent In Situ Hybridization (FISH) Probe Market is undergoing rapid expansion, fueled by the rising demand for high-precision genomic diagnostics across oncology, rare disease research, and cytogenetics. This market encompasses the development, manufacturing, and commercialization of FISH probes specialized molecular tools designed to detect and localize specific DNA or RNA sequences within intact cells or tissue samples.
These probes are essential for identifying chromosomal abnormalities, gene amplifications, deletions, or translocations, making them indispensable in both clinical diagnostics and translational research. In oncology, FISH probes are routinely deployed to support targeted therapy decisions, such as identifying HER2 gene amplification in breast cancer or ALK gene rearrangements in lung cancer. Their role is equally critical in prenatal diagnostics, hematologic malignancy evaluation, and in validating results from next-generation sequencing platforms.
Market growth is also being driven by increased adoption in academic and pharmaceutical R&D, particularly as precision medicine and biomarker-based drug development gain traction. Further, the integration of automated imaging systems with AI-driven interpretation is accelerating throughput and reducing analysis time, enhancing the clinical utility and commercial viability of FISH-based assays.
Key Market Drivers
Advancements in Genomic Research
Advancements in genomic research have revolutionized our understanding of genetics, enabling breakthroughs in disease diagnosis, treatment, and prevention. One of the key technologies driving progress in this field is Fluorescent In Situ Hybridization (FISH), which allows researchers to visualize and locate specific DNA sequences within cells. As genomic research continues to evolve, so does the demand for FISH probes, making them a pivotal component of the Global FISH Probe Market. The sequencing of the human genome marked a monumental achievement in the field of genomics. It provided researchers with a comprehensive map of our genetic makeup, comprising over 20,000 protein-coding genes. However, understanding the functions and interactions of these genes requires tools like FISH probes to visualize their activity within cells. As genomics delves deeper into gene function, the demand for FISH probes increases. Genomic research has been instrumental in identifying genetic mutations that cause diseases. Whether it's rare genetic disorders or common ailments like cancer, researchers are increasingly using FISH probes to pinpoint specific mutations within the genome. This has significant implications for diagnosis, prognosis, and targeted therapies, driving the need for more advanced FISH probes. Advancements in genomics have ushered in the era of personalized medicine. By analyzing an individual's genetic profile, clinicians can tailor treatments to a patient's unique genetic makeup. FISH probes play a critical role in this process by helping identify specific genetic markers and abnormalities.
As personalized medicine gains traction, so does the demand for FISH probes that enable precise genetic analysis. Genomic research has revealed the genetic underpinnings of complex diseases like Alzheimer's, diabetes, and heart disease. Investigating these conditions often requires an in-depth understanding of genetic variations and gene expression patterns. FISH probes provide researchers with the tools to study these complexities at the cellular level, advancing our knowledge of disease mechanisms and potential therapeutic targets. The pharmaceutical industry heavily relies on genomic research to discover new drug targets and develop precision medicines. FISH probes are essential in validating potential drug targets by confirming the presence or absence of specific genetic markers in cellular models. This accelerates drug development and fuels the demand for FISH probes in research and development. Both academic research institutions and clinical laboratories benefit from advancements in genomics. Researchers in these settings use FISH probes for a wide range of applications, from studying basic biological processes to diagnosing genetic disorders. As research expands and diversifies, so does the market for FISH probes.
Key Market Challenges
Competitive Market Dynamics
Competition in the FISH Probe Market is fierce, with several major players and numerous smaller companies vying for market share. This competition can lead to price wars and pressure on profit margins. Differentiating products becomes crucial in this environment.
Key Market Trends
Expanding Applications in Non-Invasive Prenatal Testing (NIPT)
Non-invasive prenatal testing (NIPT) is revolutionizing prenatal care by allowing the detection of fetal chromosomal abnormalities through a simple blood test. FISH probes are becoming increasingly important in NIPT, enabling the identification of specific chromosomal disorders. The expansion of NIPT applications is expected to drive down the demand for FISH probes.
Key Market Players
In this report, the Global Fluorescent In Situ Hybridization Probe Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Fluorescent In Situ Hybridization Probe Market.
Available Customizations:
Global Fluorescent In Situ Hybridization Probe market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
These probes are essential for identifying chromosomal abnormalities, gene amplifications, deletions, or translocations, making them indispensable in both clinical diagnostics and translational research. In oncology, FISH probes are routinely deployed to support targeted therapy decisions, such as identifying HER2 gene amplification in breast cancer or ALK gene rearrangements in lung cancer. Their role is equally critical in prenatal diagnostics, hematologic malignancy evaluation, and in validating results from next-generation sequencing platforms.
Market growth is also being driven by increased adoption in academic and pharmaceutical R&D, particularly as precision medicine and biomarker-based drug development gain traction. Further, the integration of automated imaging systems with AI-driven interpretation is accelerating throughput and reducing analysis time, enhancing the clinical utility and commercial viability of FISH-based assays.
Key Market Drivers
Advancements in Genomic Research
Advancements in genomic research have revolutionized our understanding of genetics, enabling breakthroughs in disease diagnosis, treatment, and prevention. One of the key technologies driving progress in this field is Fluorescent In Situ Hybridization (FISH), which allows researchers to visualize and locate specific DNA sequences within cells. As genomic research continues to evolve, so does the demand for FISH probes, making them a pivotal component of the Global FISH Probe Market. The sequencing of the human genome marked a monumental achievement in the field of genomics. It provided researchers with a comprehensive map of our genetic makeup, comprising over 20,000 protein-coding genes. However, understanding the functions and interactions of these genes requires tools like FISH probes to visualize their activity within cells. As genomics delves deeper into gene function, the demand for FISH probes increases. Genomic research has been instrumental in identifying genetic mutations that cause diseases. Whether it's rare genetic disorders or common ailments like cancer, researchers are increasingly using FISH probes to pinpoint specific mutations within the genome. This has significant implications for diagnosis, prognosis, and targeted therapies, driving the need for more advanced FISH probes. Advancements in genomics have ushered in the era of personalized medicine. By analyzing an individual's genetic profile, clinicians can tailor treatments to a patient's unique genetic makeup. FISH probes play a critical role in this process by helping identify specific genetic markers and abnormalities.
As personalized medicine gains traction, so does the demand for FISH probes that enable precise genetic analysis. Genomic research has revealed the genetic underpinnings of complex diseases like Alzheimer's, diabetes, and heart disease. Investigating these conditions often requires an in-depth understanding of genetic variations and gene expression patterns. FISH probes provide researchers with the tools to study these complexities at the cellular level, advancing our knowledge of disease mechanisms and potential therapeutic targets. The pharmaceutical industry heavily relies on genomic research to discover new drug targets and develop precision medicines. FISH probes are essential in validating potential drug targets by confirming the presence or absence of specific genetic markers in cellular models. This accelerates drug development and fuels the demand for FISH probes in research and development. Both academic research institutions and clinical laboratories benefit from advancements in genomics. Researchers in these settings use FISH probes for a wide range of applications, from studying basic biological processes to diagnosing genetic disorders. As research expands and diversifies, so does the market for FISH probes.
Key Market Challenges
Competitive Market Dynamics
Competition in the FISH Probe Market is fierce, with several major players and numerous smaller companies vying for market share. This competition can lead to price wars and pressure on profit margins. Differentiating products becomes crucial in this environment.
Key Market Trends
Expanding Applications in Non-Invasive Prenatal Testing (NIPT)
Non-invasive prenatal testing (NIPT) is revolutionizing prenatal care by allowing the detection of fetal chromosomal abnormalities through a simple blood test. FISH probes are becoming increasingly important in NIPT, enabling the identification of specific chromosomal disorders. The expansion of NIPT applications is expected to drive down the demand for FISH probes.
Key Market Players
- Thermo Fisher Scientific Inc.
- PerkinElmer Health Sciences Inc
- Biodot Inc
- New Horizons Diagnostic Corp
- Merck KGaA
- Agilent Technologies, Inc.
- Abnova Corp.
- Genemed Biotechnologies Inc
- F. Hoffmann-La Roche Ltd
- Oxford Gene Technology Ltd
In this report, the Global Fluorescent In Situ Hybridization Probe Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Fluorescent In Situ Hybridization Probe Market, By Technology:
- Q FISH
- FLOW FISH
- Others
- Fluorescent In Situ Hybridization Probe Market, By Type:
- DNA
- RNA
- mRNA
- miRNA
- Others
- Fluorescent In Situ Hybridization Probe Market, By Application:
- Cancer Research
- Genetic Diseases
- Others
- Fluorescent In Situ Hybridization Probe Market, By End-Use:
- Research
- Clinical
- Companion Diagnostics
- Fluorescent In Situ Hybridization Probe Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Company Profiles: Detailed analysis of the major companies present in the Global Fluorescent In Situ Hybridization Probe Market.
Available Customizations:
Global Fluorescent In Situ Hybridization Probe market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Q FISH, FLOW FISH, Others)
5.2.2. By Type (DNA, RNA (mRNA, miRNA, Others))
5.2.3. By Application (Cancer Research, Genetic Diseases, Others)
5.2.4. By End-Use (Research, Clinical, Companion Diagnostics)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Product Market Map
6. NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Type
6.2.3. By Application
6.2.4. By End-Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Fluorescent In Situ Hybridization Probe Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Type
6.3.1.2.3. By Application
6.3.1.2.4. By End-Use
6.3.2. Canada Fluorescent In Situ Hybridization Probe Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Type
6.3.2.2.3. By Application
6.3.2.2.4. By End-Use
6.3.3. Mexico Fluorescent In Situ Hybridization Probe Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Type
6.3.3.2.3. By Application
6.3.3.2.4. By End-Use
7. EUROPE FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Type
7.2.3. By Application
7.2.4. By End-Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Fluorescent In Situ Hybridization Probe Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Type
7.3.1.2.3. By Application
7.3.1.2.4. By End-Use
7.3.2. United Kingdom Fluorescent In Situ Hybridization Probe Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End-Use
7.3.3. France Fluorescent In Situ Hybridization Probe Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End-Use
7.3.4. Italy Fluorescent In Situ Hybridization Probe Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Type
7.3.4.2.3. By Application
7.3.4.2.4. By End-Use
7.3.5. Spain Fluorescent In Situ Hybridization Probe Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Type
7.3.5.2.3. By Application
7.3.5.2.4. By End-Use
8. ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Type
8.2.3. By Application
8.2.4. By End-Use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Fluorescent In Situ Hybridization Probe Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End-Use
8.3.2. Japan Fluorescent In Situ Hybridization Probe Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End-Use
8.3.3. India Fluorescent In Situ Hybridization Probe Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End-Use
8.3.4. Australia Fluorescent In Situ Hybridization Probe Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Type
8.3.4.2.3. By Application
8.3.4.2.4. By End-Use
8.3.5. South Korea Fluorescent In Situ Hybridization Probe Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Type
8.3.5.2.3. By Application
8.3.5.2.4. By End-Use
9. SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Type
9.2.3. By Application
9.2.4. By End-Use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Fluorescent In Situ Hybridization Probe Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End-Use
9.3.2. Argentina Fluorescent In Situ Hybridization Probe Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End-Use
9.3.3. Colombia Fluorescent In Situ Hybridization Probe Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End-Use
10. MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Type
10.2.3. By Application
10.2.4. By End-Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Fluorescent In Situ Hybridization Probe Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Type
10.3.1.2.3. By Application
10.3.1.2.4. By End-Use
10.3.2. Saudi Arabia Fluorescent In Situ Hybridization Probe Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Type
10.3.2.2.3. By Application
10.3.2.2.4. By End-Use
10.3.3. UAE Fluorescent In Situ Hybridization Probe Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Type
10.3.3.2.3. By Application
10.3.3.2.4. By End-Use
10.3.4. Kuwait Fluorescent In Situ Hybridization Probe Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Technology
10.3.4.2.2. By Type
10.3.4.2.3. By Application
10.3.4.2.4. By End-Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Thermo Fisher Scientific Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. PerkinElmer Health Sciences Inc
14.3. Biodot Inc
14.4. New Horizons Diagnostic Corp
14.5. Merck KGaA
14.6. Agilent Technologies, Inc.
14.7. Abnova Corp.
14.8. Genemed Biotechnologies Inc
14.9. F. Hoffmann-La Roche Ltd
14.10. Oxford Gene Technology Ltd
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Q FISH, FLOW FISH, Others)
5.2.2. By Type (DNA, RNA (mRNA, miRNA, Others))
5.2.3. By Application (Cancer Research, Genetic Diseases, Others)
5.2.4. By End-Use (Research, Clinical, Companion Diagnostics)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Product Market Map
6. NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Type
6.2.3. By Application
6.2.4. By End-Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Fluorescent In Situ Hybridization Probe Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Type
6.3.1.2.3. By Application
6.3.1.2.4. By End-Use
6.3.2. Canada Fluorescent In Situ Hybridization Probe Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Type
6.3.2.2.3. By Application
6.3.2.2.4. By End-Use
6.3.3. Mexico Fluorescent In Situ Hybridization Probe Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Type
6.3.3.2.3. By Application
6.3.3.2.4. By End-Use
7. EUROPE FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Type
7.2.3. By Application
7.2.4. By End-Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Fluorescent In Situ Hybridization Probe Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Type
7.3.1.2.3. By Application
7.3.1.2.4. By End-Use
7.3.2. United Kingdom Fluorescent In Situ Hybridization Probe Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End-Use
7.3.3. France Fluorescent In Situ Hybridization Probe Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End-Use
7.3.4. Italy Fluorescent In Situ Hybridization Probe Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Type
7.3.4.2.3. By Application
7.3.4.2.4. By End-Use
7.3.5. Spain Fluorescent In Situ Hybridization Probe Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Type
7.3.5.2.3. By Application
7.3.5.2.4. By End-Use
8. ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Type
8.2.3. By Application
8.2.4. By End-Use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Fluorescent In Situ Hybridization Probe Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End-Use
8.3.2. Japan Fluorescent In Situ Hybridization Probe Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End-Use
8.3.3. India Fluorescent In Situ Hybridization Probe Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End-Use
8.3.4. Australia Fluorescent In Situ Hybridization Probe Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Type
8.3.4.2.3. By Application
8.3.4.2.4. By End-Use
8.3.5. South Korea Fluorescent In Situ Hybridization Probe Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Type
8.3.5.2.3. By Application
8.3.5.2.4. By End-Use
9. SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Type
9.2.3. By Application
9.2.4. By End-Use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Fluorescent In Situ Hybridization Probe Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End-Use
9.3.2. Argentina Fluorescent In Situ Hybridization Probe Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End-Use
9.3.3. Colombia Fluorescent In Situ Hybridization Probe Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End-Use
10. MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Type
10.2.3. By Application
10.2.4. By End-Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Fluorescent In Situ Hybridization Probe Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Type
10.3.1.2.3. By Application
10.3.1.2.4. By End-Use
10.3.2. Saudi Arabia Fluorescent In Situ Hybridization Probe Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Type
10.3.2.2.3. By Application
10.3.2.2.4. By End-Use
10.3.3. UAE Fluorescent In Situ Hybridization Probe Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Type
10.3.3.2.3. By Application
10.3.3.2.4. By End-Use
10.3.4. Kuwait Fluorescent In Situ Hybridization Probe Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Technology
10.3.4.2.2. By Type
10.3.4.2.3. By Application
10.3.4.2.4. By End-Use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Thermo Fisher Scientific Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. PerkinElmer Health Sciences Inc
14.3. Biodot Inc
14.4. New Horizons Diagnostic Corp
14.5. Merck KGaA
14.6. Agilent Technologies, Inc.
14.7. Abnova Corp.
14.8. Genemed Biotechnologies Inc
14.9. F. Hoffmann-La Roche Ltd
14.10. Oxford Gene Technology Ltd
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
